Fidelity's topnotch asset-allocation team, research-intensive approach, and multitude of well-regarded underlying strategies across asset classes help the Fidelity Advisor Freedom target-date series stand out.
Fidelity Advisor Freedom 2015 A FFVAX
- NAV / 1-Day Return 10.28 / −0.39 %
- Total Assets 492.9 Mil
-
Adj. Expense Ratio
- Expense Ratio 0.780%
- Distribution Fee Level Below Average
- Share Class Type Front Load
- Category Target-Date 2015
- Investment Style Large Growth
- Credit Quality / Interest Rate Sensitivity High/Moderate
- Status Open
- TTM Yield 2.22%
- Turnover 20%
USD | NAV as of Apr 25, 2024 | 1-Day Return as of Apr 25, 2024, 10:10 PM GMT+0
Morningstar’s Analysis FFVAX
Will FFVAX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 72.9
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Fidelity Series Investment Grade Bond | 31.24 | 154.9 Mil | — |
Fidelity Srs 0-5 Yr Inf-Ptctd Bd Idx | 9.04 | 44.8 Mil | — |
Fidelity Series Emerging Markets Opps | 6.14 | 30.4 Mil | — |
Fidelity Srs 5+ Yr Inf-Ptctd Bd Idx | 5.00 | 24.8 Mil | — |
Fidelity Series Government Money Mkt | 4.58 | 22.7 Mil | Cash and Equivalents |
Fidelity Series Long-Term Trs Bd Idx | 3.81 | 18.9 Mil | — |
Fidelity Series Large Cap Stock | 3.78 | 18.8 Mil | — |
Fidelity Series Intl Dev Mkts Bd Idx | 3.77 | 18.7 Mil | — |
Fidelity Series Overseas | 3.40 | 16.8 Mil | — |
Fidelity Series International Growth | 3.37 | 16.7 Mil | — |